The Latest from Nutrition Business Journal
FDA targets supplements making opioid withdrawal claims
Industry InsightsFDA targets supplements making opioid withdrawal claimsFDA targets supplements making opioid withdrawal claims
The opioid crisis has spurred several supplement brands to make claims about easing withdrawal symptoms and making quitting easier, but such brands are currently facing legal action.
All Nutrition Business Journal
Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.